Michael Bodner

Equibles does not estimate personal net worth.

About Michael Bodner

Michael Bodner has spoken on 1 investor event across 1 company, most recently for Johnson & Johnson on May 19, 2026. Johnson & Johnson is classified in the Drug Manufacturers - General industry within the Healthcare sector. Other leadership on record at Johnson & Johnson includes J. Wolk (CFO), D. E. Pinto (Board Member), Daniel Pinto (Board Member) and 7 others.

Michael Bodner on recent calls

“As you were doing the intro, I was reflecting on my time at Biosense back in 2022. Back then, it was an $8 billion market. Four years later, it's doubled. It's now $16 billion.”

Other, Johnson & Johnson to Participate in the 2026 RBC Capital Markets Global Healthcare Conference · May 19, 2026

Affiliation history

Johnson & Johnson (JNJ)
Transcript header (unverified)

Current

Company network

Johnson & Johnson

JNJ

Current role

Drug Manufacturers - General · Healthcare

1 appearance Latest appearance 2026-05-19

View calls and events

Leadership on record at Johnson & Johnson

J. Wolk CFO
D. E. Pinto Board Member
Daniel Pinto Board Member
Darius Adamczyk Board Member
Dr. Nadja West Board Member
E. A. Woods Board Member
Eugene A. Woods Board Member
H. Joly Board Member
J. A. Doudna Board Member
J. Duato Board Member

Recent activity

Conference Johnson & Johnson to Participate in the 2026 RBC Capital Markets Global Healthcare Conference Johnson & Johnson (JNJ)
2026-05-19